Table 1.
Sociodemographic and baseline characteristics of study participants.
| Characteristics | Total (n = 200) (n = %) | Cr Ag Pos (n = 8); (n = %) | Cr Ag Neg (n = 192); (n = %) | p value | |
|---|---|---|---|---|---|
| Sex | Male | 105 (52.5) | 2 (1.9) | 103 (98.1) | 0.001 |
| Female | 95 (47.5) | 6 (5.7) | 88 (94.3) | ||
| Age in years | 15–25 | 8 (4) | 1 (12.5) | 7 (87.5) | 0.437 |
| 26–35 | 68 (34) | 3 (4.4) | 65 (95.6) | ||
| 36–45 | 77 (38.5) | 4 (5.4) | 73 (94.6) | ||
| 46–55 | 40 (20) | — | 40 (100) | ||
| >56 | 7 (3.5) | — | 7 (100) | ||
| Residence | Urban | 158 (79) | 4 (2.51) | 154 (97.9) | 0.001 |
| Rural | 42 (21) | 4 (8.5) | 38 (96.8) | ||
| Marital status | Single | 32 (16) | 1 (3.2) | 31 (96.8) | 0.001 |
| Married | 123 (61.5) | 7 (6.0) | 116 (94.0) | ||
| Divorced | 38 (19) | — | 38 (100) | ||
| Widowed | 7 (3.5) | — | 7 (100) | ||
| CD4 count (µl) | <25 | 30 (15) | 3 (10) | 27 (90) | 0.003 |
| 26–50 | 57 (28.5) | 1 (1.8) | 56 (98.2) | ||
| 51–75 | 69 (34.5) | 2 (2.9) | 67 (97.1) | ||
| 76–100 | 44 (22) | 2 (4.5) | 42 (95.5) | ||
| On ART | Yes | 147 (73.5) | 5 (3.4) | 142 (96.6) | 0.001 |
| No | 53 (26.5) | 3 (5.7) | 50 (94.3) | ||
| BMI | <18.5 kg/m2 | 78 (39) | 6 (8.3) | 72 (91.7) | 0.041 |
| >18.5 kg/m2 | 122 (61) | 2 (1.6) | 120 (98.4) | ||
| WHO staging | Stage I | 3 (1.5) | — | 3 (100) | 0.001 |
| Stage II | 20 (10) | — | 20 (100) | ||
| Stage III | 61 (30.5) | 3 (5.2) | 58 (94.8) | ||
| Stage IV | 116 (58) | 5 (4.5) | 111 (95.5) | ||
| Hgb | <12 mg/dl | 122 (61) | 5 (4.2) | 117 (95.8) | 0.619 |
| >12 mg/dl | 78 (39) | 3 (4.0) | 75 (96.0) | ||